19 Pulmonary Embolism Clinical Trials in Palo Alto, CA (2026)

Q: Are there pulmonary embolism clinical trials in Palo Alto?

Yes, there are 19 pulmonary embolism clinical trials currently recruiting in Palo Alto, CA.

Q: How do I join a clinical trial in Palo Alto?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you.

Q: Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Pulmonary Embolism Studies in Palo Alto

NCT06676904Recruiting

Neonatal Platelet Transfusion Threshold Trial

The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshol...

Palo Alto, CANA2,433 participantsNICHD Neonatal Research Network

View Study Details

NCT06671002Recruiting

Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial

This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eli...

Palo Alto, CAPHASE4900 participantsUniversity of Michigan

View Study Details

NCT05591118Recruiting

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients wit...

Palo Alto, CAPHASE3500 participantsNYU Langone Health

View Study Details

NCT02889016Recruiting

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dra...

Palo Alto, CA500 participantsStanford University

View Study Details

NCT06789913Recruiting

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

This is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3CA Related Overgrowth Spectrum (PROS) an...

Palo Alto, CAPHASE2277 participantsRelay Therapeutics, Inc.

View Study Details

NCT06971939Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

The purpose of this global, multicenter, open-label, Phase 4 clinical extension study is to evaluate the long-term safety and efficacy of revakinagene taroretcel-lwey (Encelto™; hereinafter referred t...

Palo Alto, CAPHASE4234 participantsNeurotech Pharmaceuticals

View Study Details

NCT06329375Recruiting

Food Insecurity Reduction & Strategy Team

This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study o...

Palo Alto, CANA160 participantsStanford University

View Study Details

NCT03546374Recruiting

Medtronic Terminate AF Study

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF)....

Palo Alto, CANA160 participantsMedtronic Cardiac Surgery

View Study Details

NCT03898596Recruiting

Umbilical Vessel Catheterization Under ECG Monitoring and Guidance

Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical are...

Palo Alto, CANA150 participantsStanford University

View Study Details

NCT06657209Recruiting

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), an...

Palo Alto, CAPHASE4104 participantsStanford University

View Study Details

NCT02215928Recruiting

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

This research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer). Genomic profili...

Palo Alto, CA100 participantsStanford University

View Study Details

NCT05634369Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docet...

Palo Alto, CAPHASE150 participantsNationwide Children's Hospital

View Study Details

NCT05587712Recruiting

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World ...

Palo Alto, CAPHASE242 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05241444Recruiting

CD4^LVFOXP3 in Participants With IPEX

This first-in-human, Phase 1 clinical trial will test the feasibility of the manufacturing and the safety of the administration of CD4\^LVFOXP3 in up to 30 evaluable human participants with IPEX and e...

Palo Alto, CAPHASE130 participantsBacchetta, Rosa, MD

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

Palo Alto, CAPHASE225 participantsHealx Limited

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

Palo Alto, CAPHASE120 participantsAdaptimmune

View Study Details

NCT06935253Recruiting

Large Language Models To Improve the Quality of Care of Cardiology Patients

This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage ...

Palo Alto, CANA12 participantsStanford University

View Study Details

NCT07282847Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

This is a single-arm, open-label, dose-escalation study to evaluate the safety, tolerability and efficacy of a single intravenous infusion of AB-1009 in adult participants with late-onset Pompe diseas...

Palo Alto, CAPHASE112 participantsAskBio Inc

View Study Details

NCT03801434Recruiting

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders....

Palo Alto, CAPHASE210 participantsWilliam Shomali

View Study Details

About Pulmonary Embolism Clinical Trials in Palo Alto

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 19 pulmonary embolism clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 5,719 participants. Research is being sponsored by NICHD Neonatal Research Network, University of Michigan, NYU Langone Health and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Palo Alto — FAQ

Are there pulmonary embolism clinical trials in Palo Alto?

Yes, there are 19 pulmonary embolism clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 19 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated September 1, 2026 from ClinicalTrials.gov